2024. ASSESSMENT OF SERUM SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) AS A POTENTIAL RISK MARKER IN OBESE WOMEN WITH PREDICTIVE MARKER FOR POLYCYSTIC OVARY SYNDROME. CAHIERS MAGELLANES-NS. 6, 2 (Sep. 2024), 4972–4983.